| Message: | Dexamethasone Sustained Release Microgranules
Drug Name: dexamethasone release particulate
English: Dexamethasone Sustained Release Microgranules
indications: apply to the cataract extraction and intraocular lens implantation - induced postoperative ocular inflammation.
usage and consumption: in ophthalmic surgery and the end of viscoelastic material removed, with Precision Gear forceps removed from the packaging of the goods into an immediate or after the Housing Authority. If on the anterior chamber, iris should be placed on drug tablets basement 12:00 position; If on the post should be placed on artificial iris and lens surface before the 6:00 position, then conventional incision closed.
before use and the materials used to be in a sterile condition, unless immediate using this or any other time should not be open foil packaging.
adverse reaction: in clinical trials and found no implantation of the goods directly related systemic adverse reactions and local stimulus. Commodities generally will not cause the elevation of intraocular pressure; Because of individual differences, there will be dual elevation of intraocular pressure, but are reversible, can be returned to normal after treatment.
(2) nursing: the surface with systemic absorption of the hormone. Breastfeeding may be due to the adverse reaction, according to the clinical recommendations weighing the pros and cons, or stop breastfeeding, or cancel medication.
(3) with children: children with no right to test the effectiveness of security.
specifications: 0.06mg.
Storage: shading confined preservation.
Validity: tentative year and a half. More information:
Website:http://yc1234567.chemdrug.com/
QQ:2355880530
Email:ycyy32@yccreate.com
|
my account
